111 Capital’s Exponent EXPO Stock Holding History

111 Capital’s Portfolio EXPO Stock Details EXPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,127	Closed	-$308K	–	542
2025 Q2	$308K	Sell	4,127 -867	-17%	-$67.2K	0.05%	351
2025 Q1	$405K	Buy	+4,994	New	+$435K	0.08%	262

Other funds holding EXPO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

111 Capital's EXPO Position: Q3 2025 in Review

111 Capital sold out of Exponent (EXPO) in Q3 2025, closing a stake of 4,127 shares — an estimated $308K sold.

111 Capital first reported a position in EXPO in Q1 2025 and held it in 2 quarters. The position peaked at $405K in Q1 2025. 359 funds tracked by Wall St. Rank hold EXPO as of Q3 2025.

111 Capital reported no remaining Exponent position as of Q3 2025 after selling out during the quarter.
111 Capital sold 4,127 Exponent shares in Q3 2025, an estimated $308K.
111 Capital first reported a position in Exponent in Q1 2025 and held it in 2 quarters.
111 Capital's Exponent position peaked at $405K in Q1 2025.
359 funds tracked by Wall St. Rank held Exponent as of Q3 2025.

Based on 111 Capital's 13F filing for Q3 2025, filed 12 Nov 2025.